These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Triamcinolone in the treatment of the diabetic macular edema--one-year results]. Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654 [TBL] [Abstract][Full Text] [Related]
5. Macular function by multifocal electroretinogram in diabetic macular edema after intravitreal triamcinolone acetonide injection. Karacorlu M; Ozdemir H; Senturk F; Arf Karacorlu S; Uysal O Eur J Ophthalmol; 2008; 18(4):601-8. PubMed ID: 18609482 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series. Nicolò M; Nasciuti F; Lai S; Ghiglione D; Borgia L; Calabria G Eur J Ophthalmol; 2006; 16(1):129-33. PubMed ID: 16496256 [TBL] [Abstract][Full Text] [Related]
7. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. Batioğlu F; Ozmert E; Parmak N; Celik S Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151 [TBL] [Abstract][Full Text] [Related]
8. Diabetic macular edema before and after intravitreal triamcinolone injection. Ramezani A; Tabatabaie H; Ahmadieh H Korean J Ophthalmol; 2007 Jun; 21(2):95-9. PubMed ID: 17592240 [TBL] [Abstract][Full Text] [Related]
9. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial. Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study. Grenga P; Lupo S; Domanico D; Vingolo EM Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema. Dehghan MH; Ahmadieh H; Ramezani A; Entezari M; Anisian A Int Ophthalmol; 2008 Feb; 28(1):7-17. PubMed ID: 17589809 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema. Cellini M; Pazzaglia A; Zamparini E; Leonetti P; Campos EC BMC Ophthalmol; 2008 Mar; 8():5. PubMed ID: 18366650 [TBL] [Abstract][Full Text] [Related]